Ohio residents diagnosed with mesothelioma have several choices for treatment. Ohio mesothelioma treatment and doctors can be found at three world-class cancer centers. The experts in these treatment facilities provide innovative patient care and access to clinical trials.
Cancer Centers in Ohio
If you have received a diagnosis of mesothelioma, you have a long and difficult treatment road ahead. Ohio has three excellent choices for cancer treatment, which means you don’t have to go far from home to get the best care for this terrible disease.
Case Comprehensive Cancer Center
Located at Case Western Reserve University in Cleveland, the Case Comprehensive Cancer Center is recognized by the National Cancer Institute (NCI) for excellence in patient care and research. The Case facility is dedicated to cancer research, while treatment is through two partner institutions:
- University Hospitals Seidman Cancer Center. Seidman specifically offers treatment plans for patients with both pleural and peritoneal mesothelioma. Patients with pleural mesothelioma work with the Thoracic and Esophageal Surgery department for specialty procedures, including extrapleural pneumonectomy. Those with peritoneal mesothelioma may be eligible for cytoreductive surgery with HIPEC. Patients can also participate in clinical trials here.[1]
- Cleveland Clinic Cancer Center. This includes the Taussig Cancer Center and other locations in and around Cleveland. The Lung Cancer Program includes pleural mesothelioma, and patients benefit from collaboration between professionals with various areas of expertise. Peritoneal patients can get the HIPEC treatment here as well.[2]
The Ohio State University Comprehensive Cancer Center
The James Cancer Center in Columbus is also recognized by the NCI. The Multidisciplinary Cancer Clinic brings together experts from across specialties to collaborate on treatment plans for cancers like mesothelioma. These include both pleural and peritoneal mesothelioma.[3]
In addition to standard cancer treatments, patients at Ohio State can benefit from genetic counseling, flash proton therapy, precision medicine, and immunotherapy. Support services include cancer education, counseling, physical therapy and exercise, and spiritual care.[3]
Mesothelioma Specialists in Ohio
Ohio residents benefit from having specialists in this rare cancer working at world-class cancer centers. Experts in medical and surgical oncology can help patients battling both peritoneal and pleural mesothelioma.
John Ammori, M.D.
A surgical oncologist at the Seidman Cancer Center, Dr. Ammori also directs general surgery at the University Hospitals Medical Center. He focuses on treating patients with gastrointestinal cancers, and this includes peritoneal mesothelioma. Dr. Ammori offers cytoreductive surgery with HIPEC.[4]
Luis Argote-Greene, M.D.
Dr. Argote-Greene is a member of the thoracic surgery team at the Cleveland Clinic, which he joined in 2022. Dr. Argote-Green specializes in using video-assisted thoracic surgery procedures for minimally invasive surgery.[5]
Michael A. Valente, D.O.
Dr. Valente is a colorectal surgeon who treats patients with peritoneal mesothelioma at the Cleveland Clinic’s main campus. He offers cytoreductive surgery with HIPEC for patients who qualify for this innovative and effective treatment.[6]
Nathan Pennell, M.D.
A medical oncologist, Dr. Nathan Pennell, directs the Taussig Cancer Center’s Lung Cancer Medical Oncology Program. He leads teams of experts in various fields in crafting individualized treatment plans for pleural mesothelioma patients. Dr. Pennell specializes in rare cancers, including mesothelioma.[7]
David P. Carbone, M.D.
Dr. Carbone is the Barbara J. Bonner Chair in Lung Cancer Research at the Ohio State University. He is a leading medical oncologist with a research focus on lung cancers but also pleural mesothelioma. Dr. Carbone has been instrumental in developing better, more precise treatments involving immunotherapy and other innovative therapies.[8]
Additional Mesothelioma Specialists in Ohio
- Debora S. Bruno, M.D., medical oncologist, Seidman Cancer Center, Cleveland
- Jordan M. Cloyd, M.D., surgical oncologist, Ohio State University Comprehensive Cancer Center, Columbus
- Afshin Dowlati, M.D., medical oncologist, Seidman Cancer Center, Cleveland
- Kevin El-Hayek, M.D., surgical oncologist, MetroHealth, Cleveland
- Kai He, M.D., medical oncologist, Ohio State University Comprehensive Cancer Center, Columbus
- Melinda Hsu, M.D., thoracic medical oncologist, Seidman Cancer Center, Cleveland
- Daniel Joyce, M.D., surgical oncologist, Cleveland Clinic, Cleveland
- Peter J. Kneuertz, M.D., thoracic surgeon, Ohio State University Comprehensive Cancer Center, Columbus
- Philip Linden, M.D., thoracic surgeon, Seidman Cancer Center, Cleveland
- Robert E. Merritt, M.D., thoracic surgeon, Ohio State University Comprehensive Cancer Center, Columbus
- Pranshu Mohindra, M.D., radiation oncologist, Ohio State University Comprehensive Cancer Center, Columbus
- Sudish Murthy, M.D., thoracic surgeon, Cleveland Clinic, Cleveland
- Dwight Owen, M.D., medical oncologist, Ohio State University Comprehensive Cancer Center, Columbus
- Gregory A. Otterson, M.D., thoracic oncologist, Ohio State University Comprehensive Cancer Center, Columbus
- Peter G. Shields, M.D., medical oncologist, Ohio State University Comprehensive Cancer Center, Columbus
- James Stevenson, M.D., medical oncologist, Taussig Cancer Institute, Cleveland
Ohio Clinical Trials Recruiting Mesothelioma Patients
If you have the opportunity to qualify for a clinical trial, the benefits can be significant. These are studies of novel treatments that not everyone can access. There are risks, too, so talk to your medical team before deciding to participate. Several trials in Ohio are now recruiting mesothelioma patients. These are a few examples:
- A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors. This early study of a new medication needs patients with advanced mesothelioma. The study is testing the safety and tolerability of the new drug. Qualifying participants must have metastatic or non-resectable cancer.[9]
- Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma. Peritoneal patients may qualify for this study of standard chemotherapy compared to chemotherapy with immunotherapy.[10]
- MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma (eVOLVE-Meso). This study is recruiting pleural mesothelioma patients who are not good candidates for surgery. Researchers are investigating a new drug used in combination with standard chemotherapy.[11]
A mesothelioma diagnosis requires immediate treatment, but make sure you find a specialist equipped to manage this rare disease. Ohio is home to several excellent cancer centers, so finding good treatment does not require out-of-state travel.
